MM 19-20 Genetics Flashcards

1
Q
Rare disease:
Frequency
Cause
Character
Percent of population
Examples
A
Frequency less than 1/2000.
Normally cause by a single gene. 
Generally chronic with early onset. 
6-8% of population have a rare disease. 
Huntington's disease, Sickle-Cell anemia, Phenylketonuria.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
Common disease:
Frequency
Cause
Onset
Examples
A

Commonly occurring
Normally polygenic or multifactorial with enviro contribution.
Onset later in life
Cancer, Heart disease, Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GWAS

A

Genome Wide Association Study. Uses DNA hybridization to examine the frequency of SNPs that are present for a certain disease. Helps us to understand which genes may contribute to multifactorial diseases. Looks at thousands of genes across tens of thousands of people of healthy and diseased people, using DNA hybridization chips. Rigorous statistical analysis (P-value) used to determine which SNPs occur within an isolated disease and the extent of their effect (odds ratio).

GWAS so far has not found many complex diseases with strong, predictive odds ratios. GWAS is, however, helping us to understand the biological causes of common diseases and treat disease phenotypes more specifically by prescribing drugs more specifically. We are also learning that some drugs may work for diseases for which they weren’t made (repurposed).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

P-Value

A

Measure of statistical significance. The probability that a result occurs by chance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Odds ratio

A

The odds that a disease will occur given a particular genome, compared to the odds of a disease occurring in the incense of the genome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Schizophrenia and GWAS

A

Schizophrenia is a common disease. We now know it is highly polygenic. Identified 108 significant Loci but none of the individual odds ratios are great enough to make the test predictive.

HLA gene, however, indicates 10% increase in acquiring disorder.

Genes identified point to Ca signaling, immune disregulation, and glutamertergic neurotransmission.

So complex that individual risk profiling is not advised.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Multifactorial disease

A

A common disease resulting from polygenetic and environmental factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical relevance of genetic variation in drug metabolizing enzymes and example:

A

People break down drugs differently, depending on their genetic profile. In some cases, a drug may have contraindications or toxicity build up, while in other people a drug may have lower efficacy. Certain drugs are now recommended to be coupled with genetic testing).

EX: Azathioprine reduces DNA synthesis by inhibiting Nucleotide synthesis. Used for autoimmune disorders and cancers. The target is one of several pathways. TPMT is an enzyme that sends it down another pathway, inactivating the drug. Genetic variability in TPMT effects the efficacy and toxicity of Azathioprine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cytochrome P450 protein family (CYPs)

A

CYP450 proteins are found mostly in liver and small intestine. The CYP450 family of proteins break down drugs and hormones. There are hundreds of isoenzymes that add to complexity making high variability among individuals. It is therefore a major contributor to the variance of pharmacological effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical relevance of genetic variation in the target of drugs and example:

A

Pharmacogenetics efficacy differs from person to person due to genetic variation in the target gene. In such cases, different dosages are necessary.

Ex: Warafin has a narrow therapeutic index and must be closely monitored. The drug target is Vitamin K epoxide reductase (VKOR). Differences in this gene account for 25% of the drugs variability. So genetic testing is now recommended for determining Warafin dosages.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Clinical relevance in genetic variating in ‘off target’ genes and HLA.

A

HLA is the region that codes for Class 1, 2 and compliment immune system. It is the most diverse region of the genome. Variation within HLA contributes to various adverse immune responses to drugs.

Carbamazepine is an anti-epileptic drug that can cause Stephen Johnson Syndrome (the separation of epidermis from dermis) due to a specific HLA gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical relevance of genetic variation in a gene that causes a specific disease and example.

A

A disease phenotype can be caused by different genetic defects. Treatment depends on isolating the correct defect.

Ex: Most cystic fibrosis is caused by a defect in CFTR genes. However, a defect can alter the proteins shape, its turnover rate, its synthesis, etc. Effective treatment depends on what is wrong with the protein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Barriers to the clinical integration of pharmacogenetics tests.

A

Expensive
8-10 weeks for results
Limited interpretation of results
Many drugs yet to be studied

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Rheumatoid Arthritis and GWAS

A

Autoimmune disorder affecting joints in hands and feet. 5-10/1000. Begins at age 40+. Treated with steroids and methotrexate.

GWAS identified 101 related genes.
The genes pointed to T/B cell and cytokine cell related signaling pathways.

Risk profiling not advised.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Age Related Macular Degeneration and GWAS

A

Neurodegeneration of retina leads to vision impairment. Onset 40+.

GWAS identified 19 distinct loci. If you have 2 of them, odds of getting disease are 2-3x higher.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mercaptopurine and genetic variation

A

Mercaptopurine is an immunosuppressant used to treat acute lymphoblastic leukemia, IBS, RA. Its inhibits purine (A/G) synthesis.

Mercaptopurine is a prodrug that must first be activated to form thioguanine nucleotides (TGNs), the major active metabolites.

In most people, some of mercaptopurine is inactivated by TPMT, leaving less drug available for activity.

People with a TPMT deficiency who take a normal dose of mercaptopurine suffer from TGN toxicity, causing life threatening mylosupression (bone marrow suppression causing decreased WBCs and anemia. In such people, reducing the dosage of mercaptopurine greatly reduces the toxicity.

Therefore, genetic testing is recomended for mercaptopurine dosing.

17
Q

Cytochrome P450 - drug metabolism

A

CYT P540 family found in liver. Metabolize most drugs to a more water soluble form. Genetic variations in CYT 450 enzymes greatly affect drug availability.

This cause some prodrugs to be ineffective and others to be toxic.

18
Q

Warfarin and genetic variation

A

Vitamin K is a cofactor in synthesis of coagulation factors by VKOR (Vitamin K epoxide reductase). Warfarin is a vitamin K antagonist, slowing VKOR. Warfarin is inactivated by a CYT P450.

Warfarin has a very narrow therapeutic range and doses must be monitored carefully. Gene variation of the CYT P450 or VKOR greatly affect the efficacy of Warfarin.

The FDA recommends genetic testing for Warfarin dosing.

19
Q

Human Leukocyte Antigen (HLA) gene complex and genetic variance.

A

The HLA gene complex codes for the major histocompatibility complex (MHC). It is the most diverse region of the human genome. It regulates immune function and is a target for immune and transplant therapy.

Carbamazepine (an epilepsy drug) can cause Stevens–Johnson syndrome (SJS) in certain populations who have HLA variations.

20
Q

Stevens-Johnson Syndrome (SJS)

A

A severe epidermal necrolysis. The epidermis separates from the dermis.

The major cause is due to Carbamazepine and Allopurinol interactions in people with a HLA gene variance.

21
Q

Carbamazepine

A

An epilepsy drug that can cause Stevens -Johnson syndrome in people with a particular HLA variation.

Genetic testing is recommended for Carbamazepine, especially within the Asian population.

Different populations get carbamazepine induced SJS due to different HLA variation. Therefore, different ethnicities may require different tests.

22
Q

Allopurinol and genetic variance

A

A gout drug that is linked to SJS in people with HLA genetic variance.

23
Q

Interferon and genetic variance

A

A Hepatitis C drug with highly variable responses.

Alternative therapy should be sought if patient test positive for a particular genome.

24
Q

Cystic Fibrosis

A

One disease, caused by several different mutations to the CFTR genes, each of which is damaging in a unique way. The mutation may effect translation, synthesis, function, or turnover of the CFTR protein.

Kalydeco is a drug for cystic fibrosis that only responds well to some of the potential CFTR problems.